TYRA Stock: Tyra Biosciences, Inc. Stock Price, Analysis & Insights
Get live tyra stock price $21.00, comprehensive Tyra Biosciences, Inc. stock analysis, charts, news, and expert forecast. Real-time tyra stock data and investment insights.
Loading chart...
Company Overview
Tyra Biosciences, Inc., a preclinical-stage biopharmaceutical company, focuses on developing therapies to overcome tumor resistance and enhance outcomes for patients with cancer. Its lead product candidate is TYRA-300, a selective inhibitor of fibroblast growth factor receptor (FGFR)3 for the treatment of muscle invasive bladder cancer. The company is also developing programs targeting FGFR2- intrahepatic cholangiocarcinoma,FGFR3-related achondroplasia, REarranged during transfection kinase, and FGFR4-related cancers. In addition, the company offers SNAP platform which enable rapid structural design through iterative molecular SNAPshots. Tyra Biosciences, Inc. was incorporated in 2018 and is based in Carlsbad, California.
Company Information
- CEO
- Todd Harris
- Sector
- Healthcare
- Industry
- Biotechnology
- Employees
- 60
Contact Information
- Website
- https://www.tyra.bio
- Address
- 2656 State Street
- Country
- US
Investment Analysis & Business Insights
Investment Highlights
✓ Strong presence in the Healthcare sector with established market position
Business Model & Strategy
Tyra Biosciences, Inc. operates in the Biotechnology industry, focusing on medical services, pharmaceutical development, and healthcare delivery. Under the leadership of CEO Todd Harris, the company navigates Healthcare sector dynamics while pursuing growth opportunities. The Biotechnology model requires regulatory compliance, research investment, and patient outcomes to maintain competitiveness and drive shareholder value.
Market Position & Competitive Landscape
Tyra Biosciences, Inc. competes in the Biotechnology within the broader Healthcare. With 1.1 billion in market capitalization, the company is positioned as a emerging competitor in its sector. The Healthcare is characterized by demographic shifts, regulatory changes, and medical breakthroughs. As a publicly traded company on the NASDAQ Global Select, Tyra Biosciences, Inc. provides investors with liquidity and transparency while subject to regulatory oversight. Investors evaluating Tyra Biosciences, Inc. should consider industry-specific trends, competitive positioning, and Healthcare sector fundamentals.
Important Investment Considerations
- ⚠All investments carry risk, including potential loss of principal for Tyra Biosciences, Inc. shareholders
- ⚠Market volatility can significantly impact stock price, especially for smaller companies
- ⚠Sector-specific risks in Healthcare may affect company performance
- ⚠Past performance does not guarantee future results for Tyra Biosciences, Inc.
- ⚠Investors should consider how Tyra Biosciences, Inc. fits within their overall portfolio allocation
- ⚠Valuation metrics suggest potential, but require fundamental analysis
Market Cap
1.12B
P/E Ratio
-11.17
Beta
1.12
Investment Analysis & Insights
Key Investment Highlights
- Market Position: Healthcare leader with 1.12B market capitalization
- Trading Volume: 1.87M shares traded today
- Price Range: 52-week range of $6.42 - $21.19
- Exchange: Listed on NASDAQ Global Select
Financial Metrics
Market Analysis for Tyra Biosciences, Inc.
Tyra Biosciences, Inc. (TYRA) operates in the Biotechnology industry within the Healthcare sector. With a current market capitalization of 1.12B, the company represents a significant player in its market. The stock is currently trading at $21.00 with a positivedaily change of 26.35%.
The company's 60 employee base and presence on the NASDAQ Global Selectexchange position it as a Healthcare sector leader. Investors should consider the stock's P/E ratio of -11.17, beta of 1.12, and 52-week price range from $6.42 to $21.19when evaluating investment opportunities.
Why Invest in Tyra Biosciences, Inc.?
Strengths
- • Established market presence in Healthcare
- • Strong financial metrics and market position
- • Listed on major exchange (NASDAQ Global Select)
- • Experienced leadership under Todd Harris
Investment Considerations
- • Monitor sector-specific market trends
- • Track quarterly earnings performance
- • Consider market volatility and beta
- • Evaluate long-term growth potential
Related Healthcare Stocks
About Healthcare Sector
The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.